(Bloomberg) -- The U.S. government’s top infectious-disease expert said that early results of a closely watched clinical trial offered “quite good news” regarding a potential Covid-19 therapy made by the biotechnology company Gilead Sciences Inc.Anthony Fauci, the head of National Institute of Allergy and Infectious Diseases, which is conducting the study, said at a White House meeting with President Donald Trump and Louisiana Governor John Bel Edwards that the trial showed a significant positive effect in treating the virus.Early Wednesday morning, Gilead issued a news release saying it had become aware of results from the NIAID trial showing its experimental drug remdesivir helped patients recover more quickly than standard care, suggesting it could become the first effective treatment for an illness that has turned modern life inside-out.NIAID’s trial enrolled more than 1,000 patients internationally and compared remdesivir treatment alongside supportive care with a placebo. Patients who got the drug recovered in...
(Bloomberg) -- The U.S. proposed rules to track aluminum imports more closely, in a move that could address industry demands to block Chinese supply that skirts tariffs.While the Trump administration’s import levies are aimed at protecting against excess foreign supply of the metal, concerns have persisted that aluminum from China -- the world’s biggest producer -- is still flooding into the market.That’s because some Chinese supply could first be sent to another nation that isn’t subject to the duties. It’s then melted and reformed before being shipped again, masking its true origin. Criticism about surplus metal entering the U.S. via such transshipment and re-labeling to circumvent trade laws has preceded the Trump administration.Under the proposed new U.S. rules, importers will be required to identify the country from which the aluminum was originally obtained. They will also need to get a license for shipments. The program is modeled on a steel-import monitoring...
The American Truck Dealers is pushing congressional leaders to suspend the 12% federal excise tax on new heavy-duty trucks and trailers through 2021. ...
An experimental antiviral drug to treat COVID-19 patients has stoked high expectations in the fight against the coronavirus pandemic, which has gained a decisive foothold in the United States....
(Bloomberg) -- Gilead Sciences Inc. said early results from a U.S.-government-run study showed its experimental drug to treat coronavirus helped patients recover more quickly than standard care, suggesting it could become the first effective treatment for an illness that has turned modern life inside-out.The company issued a news release early Wednesday commenting on the study from the U.S. National Institute of Allergy and Infectious Diseases without providing details of the results.Anthony Fauci, the head of NIAID and the government’s top infectious-disease specialist, said at a White House meeting with President Donald Trump and Louisiana Governor John Bel Edwards that the trial showed a significant positive effect on the virus and that the results “were quite good news.”Fauci called the study the “first truly high-powered randomized placebo-controlled trial” of remdesivir.Gilead’s share price and the broader stock market have been churned in recent weeks by a series of early looks and leaks of...
